IGC Pharma (IGC) EPS (Basic) Growth (1y) (2011 - 2025)
IGC Pharma (IGC) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | -16.29% |
| 10 | IGC Pharma | 27.94 Mn | 27.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.89% |
| Jun 30, 2025 | 41.03% |
| Mar 31, 2025 | 79.70% |
| Dec 31, 2024 | 73.14% |
| Sep 30, 2024 | 49.95% |
| Jun 30, 2024 | 16.46% |
| Mar 31, 2024 | -141.38% |
| Dec 31, 2023 | -106.93% |
| Sep 30, 2023 | 3.53% |
| Jun 30, 2023 | 27.54% |
| Mar 31, 2023 | 76.58% |
| Dec 31, 2022 | 9.12% |
| Sep 30, 2022 | 46.20% |
| Jun 30, 2022 | -44.58% |
| Mar 31, 2022 | -86.53% |
| Dec 31, 2021 | 99.92% |
| Sep 30, 2021 | 99.78% |
| Jun 30, 2021 | 99.92% |
| Mar 31, 2021 | 95.98% |
| Dec 31, 2020 | -38.84% |